MedTrace Logo

Effect of Intravenous Dexmedetomidine Versus Dexamethasone for Management of Repound Pain After Supraclavicular Brachial Plexus Block

NCT06304909 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 111

Last updated 2026-06-24

No results posted yet for this study

Summary

Effect of intravenous dexmedetomidine versus dexamethasone for management of repound pain after supraclavicular brachial plexus block.

Conditions

  • Trauma Injury

Interventions

DRUG

Dexmedetomidine injection

Dexmedetomidine group will receive 0.5 mcg/kg

DRUG

Dexamethasone

Dexamethasone group will receive 8mg/kg

DRUG

Saline

receive equivalent volume of saline 0.9%.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Wesam Nashat Ali, professor · Assistant professor

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-05-15
Primary Completion
2025-03-10
Completion
2025-03-20

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06304909 on ClinicalTrials.gov